Flinton Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $341K | Buy |
7,648
+3,056
| +67% | +$136K | 0.01% | 558 |
|
|
2019
Q2 | $190K | Buy |
4,592
+720
| +19% | +$29.8K | 0.01% | 688 |
|
|
2019
Q1 | $157K | Buy |
3,872
+816
| +27% | +$33.1K | 0.01% | 712 |
|
|
2018
Q4 | $116K | Sell |
3,056
-6,048
| -66% | -$230K | ﹤0.01% | 739 |
|
|
2018
Q3 | $360K | Hold |
9,104
| – | – | 0.01% | 581 |
|
|
2018
Q2 | $320K | Buy |
9,104
+512
| +6% | +$18K | 0.01% | 542 |
|
|
2018
Q1 | $300K | Hold |
8,592
| – | – | 0.01% | 557 |
|
|
2017
Q4 | $298K | Hold |
8,592
| – | – | 0.01% | 561 |
|
|
2017
Q3 | $291K | Hold |
8,592
| – | – | 0.01% | 525 |
|
|
2017
Q2 | $293K | Hold |
8,592
| – | – | 0.01% | 485 |
|
|
2017
Q1 | $268K | Hold |
8,592
| – | – | 0.01% | 450 |
|
|
2016
Q4 | $235K | Buy |
+8,592
| New | +$235K | 0.01% | 429 |
|